Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05893927 · ClinicalTrials.gov registry record · NA
Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes
A NA study of Diabetes Mellitus, Type 2 and Lifestyle Modification, sponsored by The Reading Hospital and Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT05893927 is a NA study of Diabetes Mellitus, Type 2 and Lifestyle Modification that is actively recruiting participants, run by The Reading Hospital and Medical Center. The registered enrollment target is 65 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05893927, a NA study of Diabetes Mellitus, Type 2 and Lifestyle Modification, is actively recruiting participants, sponsored by The Reading Hospital and Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educational outcomes (Self-Efficacy for Diabetes Scale). The main question to answer is: Does the use of the Diabetes Application significantly affect clinical outcomes of diabetes and cardiometabolic risk factors (BMI and Blood Pressure)? Patients will be enrolled in one of two available arms of the study. Participants in the 'intervention arm' will use the app to view educational information presented as videos in the following areas: Healthy Coping, Healthy Eating, Staying Active, Medications (Use and Safety), Problem Solving in Diabetes and Disease Pathophysiology. They will continue routine follow-up care with their primary care physicians during the study. Participants in the 'control arm' will continue with their primary care physician in routine follow-up care, as normally scheduled. Researchers will compare the intervention arm participants to the control arm participants to find out about and compare changes in HA1C, systolic blood pressure, diastolic blood pressure, and body mass index. Groups will also be compared on the basis of self-perceived confidence of managing their diabetes by way of the Diabetes Self Efficacy Scale.
Conditions Studied
Interventions
- OTHER Diabetes education web site application
Study Locations (1)
Pennsylvania
- Reading Hospital, an affiliate of Tower Health - West Reading
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05893927
The ClinicalTrials.gov registry entry for NCT05893927 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is The Reading Hospital and Medical Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Diabetes education web site application is the first listed.
NCT05893927 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05893927 about?
NCT05893927 is a clinical study titled "Impact of a Diabetes Education Mobile Web Application on Patients With Uncontrolled Type 2 Diabetes". The goal of this clinical trial is to evaluate the use and effectiveness of a mobile web application (app) that is designed to educate and allow patients to manage diabetes and make sustainable lifestyle changes, and to study the impact of the app on clinical outcomes of diabetes (HA1C) and educatio...
What is the current status of trial NCT05893927?
This trial is currently recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2024-02-15. Estimated completion is 2026-09-30.
What conditions does trial NCT05893927 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2, Lifestyle Modification, Diabetes Education.
What interventions are being tested in trial NCT05893927?
The interventions under investigation include: Diabetes education web site application (OTHER).
Who is sponsoring clinical trial NCT05893927?
This trial is sponsored by The Reading Hospital and Medical Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05893927 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.